NCT01423734
- Conditions
- Gastro-enteropancreatic Neuroendocrine Tumor, Gastro-enteropancreatic neuroendocrine tumor, Secondary Malignant Neoplasm of Liver
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Clinical trial condition
Gastro-enteropancreatic neuroendocrine tumor
Explore clinical trials studying Gastro-enteropancreatic neuroendocrine tumor. Study availability and eligibility vary by location and protocol.
46 public trials
19 recruiting studies
Gastro-enteropancreatic neuroendocrine tumor trial results
Completed
Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
NCT02948946
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT03220217
- Conditions
- Gastro-enteropancreatic Neuroendocrine Tumor, Gastro-enteropancreatic neuroendocrine tumor
- Locations
-
- UCLA Medical Center Los Angeles, California, United States
- Medical University of Innsbruck Innsbruck, Austria
- University Clinic for Radiology and Nuclear Medicine Vienna, Austria
- Aarhus University Hospital Aarhus, Denmark
NCT01476592
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Neoplasms, Neoplasms by Histologic Type, +5 more
- Locations
-
- University of Wisconsin Madison, Wisconsin, United States
NCT03017690
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor
- Locations
-
- The University of Arizona Cancer Center Tucson, Arizona, United States
- Ochsner Medical Center Kenner Kenner, Louisiana, United States
- Mercy Medical Center Baltimore, Maryland, United States
- National Translational Research Group East Setauket, New York, United States
Active, Not Recruiting
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET
NCT05050942
- Conditions
- Gastro-enteropancreatic Neuroendocrine Tumor, Gastro-enteropancreatic neuroendocrine tumor
- Locations
-
- Mayo Clinic Cancer Center (MCCC) - Phoenix Phoenix, Arizona, United States
- UCLA Ahmanson Biological Imaging Center Santa Monica, California, United States
- Rocky Mountain Cancer Centers - Denver - Midtown Denver, Colorado, United States
- Mayo Clinic Hospital - Florida Jacksonville, Florida, United States
NCT06790706
- Conditions
- Adenocarcinoma, Anaplastic Thyroid Carcinomas, Carcinoid Tumor, +27 more
- Locations
-
- Institut de Cancerologie de l'Ouest , medical oncology department Angers, France
- Institut Bergonié, medical oncology department Bordeaux, France
- Hospices Civils de Lyon, Thoracic Oncology Department, Louis Pradel Hospital Bron, France
- Centre Hospitalier Universitaire de Lille, medical oncology department Lille, France
Active, Not Recruiting
Multicenter Trial of ESK981 in Patients With Select Solid Tumors
NCT05988918
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +27 more
- Locations
-
- Rogel Cancer Center Ann Arbor, Michigan, United States
- University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
Active, Not Recruiting
A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)
NCT03833700
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +30 more
- Locations
-
- Eisai Trial Site#7 Nagoya, Aichi-ken, Japan
- Eisai Trial Site #2 Kashiwa, Chiba, Japan
- Eisai Trial Site #5 Sapporo, Hokkaido, Japan
- Eisai Trial Site#8 Sendai, Miyagi, Japan
Active, Not Recruiting
Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs
NCT04711135
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumors, Neoplasms, +7 more
- Locations
-
- University of Kentucky Lexington, Kentucky, United States
- Cincinnati Children's Hospital Cincinnati, Ohio, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
- Centre Léon Berard Lyon, France